Clinical Trial Update: Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer

View source ↗

Summary

This clinical trial update notes the termination of a study evaluating molecular characterization of circulating tumor cells (CTCs) and circulating tumor DNA (c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Southern California | Conditions: Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma | Status: TERMINATED